JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

Clinical trial NCT06797024 · RECRUITING

Trial details

NCT number: NCT06797024
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Autoimmune Diseases of the Nervous System

Start date: 2025-02-28
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.